In the Dutch HEBON cohort, death from breast cancer was seen in 2% of BRCA1 carriers electing for surveillance vs. 0.1% of BRCA1 carriers electing for bilateral RRM (HR 0.06, 95% CI 0.01–0.46). The gene discussed is BRCA1; the disease is breast carcinoma.